Analytical Data
-
Gene name
LAB7-1
- Application
-
Alternative Names
CD80; CD28LG; CD28LG1; BB1; B7-1 Antigen; T-lymphocyte activation antigen CD80; CTLA-4 counter-receptor B7.1
-
Species
Rat
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
G3V671
-
Expression Region
Gly41~Gln248
-
Molecular Weight
30kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LAB7-1 is a recombinant protein that has gained significant attention in the fields of molecular biology and biotechnology due to its potential applications in therapeutics and diagnostics. The research surrounding LAB7-1 primarily focuses on understanding its structure, function, and mechanisms of action. As a recombinant protein, LAB7-1 is produced through genetic engineering techniques that allow for the insertion of specific genes into host organisms, enabling the efficient synthesis of the target protein. This approach not only facilitates large-scale production but also allows for modifications to enhance the protein's stability and activity. LAB7-1 has shown promise in various applications, such as acting as a biomarker for certain diseases, serving as a tool for drug delivery, and contributing to vaccine development. Moreover, the characterizations of LAB7-1's binding properties and interactions with other biomolecules are crucial for elucidating its role in biological pathways. The ongoing research aims to optimize the production process, explore its functional properties, and assess its therapeutic potential, particularly in the context of personalized medicine and targeted therapies. Overall, LAB7-1 represents a valuable tool in the advancement of protein engineering and biomedicine, highlighting the importance of recombinant proteins in modern scientific research.
